Trial NCT04095689

View at ClinicalTrials.gov 
Org. Study IDs: PRO00028602

Last trial update was posted on 2024-02-21

MeSH Interventions

Docetaxel Pembrolizumab

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Anthracycline-refractory TNBC Triple Negative Breast Cancer

Stopping Reasons

Stopping rules met per protocol, comprehensive review needed prior to enrolling again

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID